Arlo-cel (arlocabtagene autoleucel)- A GPRC5D-Directed CAR-T Therapy on the Horizon for Myeloma
Автор: HealthTree University for Multiple Myeloma
Загружено: 2026-03-05
Просмотров: 371
Описание:
Arlo-cel is an experimental CAR-T therapy targeting GPRC5D, a protein on myeloma cells. It reprograms a patient’s T cells to attack the cancer, offering hope for relapsed or resistant myeloma. This HealthTree University video will give you a brief update on this Therapy on the Horizon.
If this video has helped you or a loved one, consider donating to HealthTree. Every donation helps us continue to create free and high-quality blood cancer educational content: https://give.healthtree.org/give/6286...
For an organized lesson structure, watch on our site here: https://linktr.ee/HealthTreeUniversity
Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer!
Patients have the key to find cures for cancer. Learn more about HealthTree's services here: https://healthtree.org/curehub?utm_so...
Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
